Abstract B25: First-in-human Phase I study to evaluate MP0250, a DARPin blocking HGF and VEGF, in patients with advanced solid tumors by Rodon, Jordi, Omlin, Aurelius, Herbschleb, Karin H., Garcia-Corbacho, Javier, Steiner, Jan, Dolado, Ignacio, Zitt, Christof, Feurstein, Daniel, Turner, Dascha, Dawson, Keith M., Stumpp, Michael T., Gilboy, Patrick, Harstrick, Andreas, Azaro, Analía, Ackermann, Christoph J., Middleton, Mark R., Baird, Richard D.

Get full text